After seeking care for escalating memory lapses, Diane Roussel received a devastating Alzheimer's diagnosis. She began ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Alzheimer’s disease has long been a diagnosis that arrives only after memory begins to fray, by which time brain damage is ...

The findings add to previous research at CU Anschutz which found that Alzheimer’s patients given Leukine showed improvement ...

A new study published on Thursday, Oct. 24, 2024, showed potentially promising results in Alzheimer's and dementia prevention: It's the third such study that indicates that semaglutides, the active ...

Scientists said a novel compound can arrest early stages of Alzheimer's disease in mice brains, setting the stage for a ...

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

DAVENPORT, Iowa — While millions of people struggle with Alzheimer's disease, no approved treatment is available, however, a new drug awaiting FDA approval could prevent the early onset of the disease ...

The Alzheimer’s medication Aduhelm is being discontinued by drugmaker Biogen as it shifts resources to its other Alzheimer’s medication, Leqembi, and developing other treatments, the company said in a ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore ‌a shift ​to approaching the brain-wasting disease as a system of ...

Scientists reversed advanced Alzheimer's in mice using a compound that restores cellular energy. The breakthrough challenges ...

A medication designed to slow early Alzheimer’s disease (AD) may soon have a new dosing schedule. The medication, Leqembi, is currently administered via an infusion every two weeks. Once it’s in the ...